Drug ID: | NPD4160 |
Drug Name: | |
Molecular Formula: | C20H27NO3 |
Canonical SMILES: | NC[C@@H]1OC(Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 |
Standard InCHI: | InChI=1S/C20H27NO3/c21-10-17-14-1-2-16(22)19(23)15(14)6-18(24-17)20-7-11-3-12(8-20)5-13(4-11)9-20/h1-2,11-13,17-18,22-23H,3-10,21H2/t11?,12?,13?,17-,18?,20?/m0/s1 |
Standard InCHIKey: | QLJOSZATCBCBDR-AFGGPKNVSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7